IFM Investors Pty Ltd boosted its position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 2.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 421,486 shares of the biopharmaceutical company’s stock after purchasing an additional 8,875 shares during the period. IFM Investors Pty Ltd’s holdings in Bristol Myers Squibb were […]

ING Groep NV reduced its position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 66.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 324,977 shares of the biopharmaceutical company’s stock after selling 638,156 shares during the quarter. ING Groep NV’s holdings […]

Vise Technologies Inc. lifted its position in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 34.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 72,138 shares of the biopharmaceutical company’s stock after purchasing an additional 18,547 shares during the period. Vise Technologies Inc.’s holdings in Bristol Myers Squibb were worth $3,891,000 at the […]